Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Common Stock Subscribed
Additional Paid-in Capital
Subscription Receivable
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 2,317 $ 161,300,916 $ 136,177 $ (117,218,584) $ 44,220,826
Balance (in Shares) at Dec. 31, 2019 23,176,146
Common stock issued for cash $ 76 4,999,924 5,000,000
Common stock issued for cash (in Shares) 758,725
Stock-based compensation:
Restricted common stock 113,436 113,436
Restricted common stock (in Shares)
Stock options 240,399 240,399
Stock options (in Shares)
Subscription of common stock in connection with exercise of put option $ 102 1,999,898 $ (2,000,000)
Subscription of common stock in connection with exercise of put option (in Shares) 1,018,848
Net loss (8,776,469) (8,776,469)
Balance at Mar. 31, 2020 $ 2,393 $ 102 168,654,573 (2,000,000) 136,177 (125,995,053) 40,798,192
Balance (in Shares) at Mar. 31, 2020 23,934,871 1,018,848
Balance at Dec. 31, 2020 $ 3,851 195,488,181 190,966 (162,277,414) 33,405,584
Balance (in Shares) at Dec. 31, 2020 38,506,844
Stock-based compensation:
Common stock $ 13 199,987 200,000
Common stock (in Shares) 126,584
Restricted common stock 80,006 80,006
Restricted common stock (in Shares)
Stock options 282,999 282,999
Stock options (in Shares)
Shares issued for redemption of debt and accrued interest $ 53 821,814 821,867
Shares issued for redemption of debt and accrued interest (in Shares) 529,383
Net loss (3,336,676) (3,336,676)
Other comprehensive income 25,336 25,336
Balance at Mar. 31, 2021 $ 3,917 $ 196,872,987 $ 216,302 $ (165,614,090) $ 31,479,116
Balance (in Shares) at Mar. 31, 2021 39,162,811